IONIS PHARMACEUTICALS INC — Director's Dealing 2018

Jul 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2018-07-01

Reporting Person: HOUGEN ELIZABETH L (SVP Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-01	Common Stock	J	274	$35.4195	Acquired	14774	Direct

Footnotes

F1: Reporting 274 shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on July 1, 2018. These 274 shares may not be sold until January 2, 2019.